{
  "retracted": false,
  "timestamp": 1544486400000,
  "updates": [
    {
      "timestamp": 1581430209362,
      "identifier": {
        "doi": "10.1182/bloodadvances.2018028944"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1182/bloodadvances.2017011999"
  },
  "publisher": "American Society of Hematology",
  "title": "Bye AP, Unsworth AJ, Desborough MJ, et al. Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib. Blood Adv. 2017;1(26):2610-2623."
}
